These results suggested that as a small molecule compound targeted to YY1, the tumor suppressive effects of JAC1 on TNBC includes at least the following two paths: on the one hand, it released the effect of downstream tumor suppressive target genes such as JWA; On the other hand, it reduced the role of downstream oncogenes such as HSF1. The gene discussed is ARL6IP5; the disease is neoplasm.